Colorectal Cancer Screening

Oncology
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

EXACT Therapeutics
EXACT TherapeuticsNorway - Oslo
1 program
CologuardN/A1 trial
Active Trials
NCT02419716Completed2,404Est. Mar 2020
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Positive Fit to Colonoscopy: Closing the GapN/A1 trial
Active Trials
NCT06763432Recruiting45Est. Aug 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Johnson & JohnsonPositive Fit to Colonoscopy: Closing the Gap
EXACT TherapeuticsCologuard

Clinical Trials (2)

Total enrollment: 2,449 patients across 2 trials

NCT06763432Johnson & JohnsonPositive Fit to Colonoscopy: Closing the Gap

Positive Fit to Colonoscopy: Closing the Gap

Start: Jun 2025Est. completion: Aug 202945 patients
N/ARecruiting

A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval

Start: Apr 2015Est. completion: Mar 20202,404 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 2,449 patients
2 companies competing in this space